News & Events about Vicarious Surgical Inc.
Vicarious Surgical, Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company earned recognition from Fast Company and the MedTech Breakthrough...
Ticker Report
2 months ago
Vicarious Surgical Inc (NYSE:RBOT Get Rating) Director Philip Liang acquired 73,500 shares of the businesss stock in a transaction on Thursday, March 23rd. The stock was bought at an average cost of $1.71 per share, for a total transaction of $125,685.00. Following the completion of ...
Business Wire
3 months ago
Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that the company will be participating in the following upcoming investor conferences...
Business Wire
3 months ago
Vicarious Surgical Inc. (Vicarious Surgical or the Company) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December...
Business Wire
6 months ago
Vicarious Surgical Inc. (Vicarious Surgical'' or the Company), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced that renowned surgeon Igor Belyansky, MD, used the Vicarious Surgical Beta 2 prototype, to successfully...